SEC Form 4 · accession 0001179110-17-009206
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jared Watkin
Officer — Senior Vice President
Period of report
Jun 15, 2017
Accepted (ET)
Jun 16, 2017 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jun 15, 2017 | F | 1,421 | $47.64 | D | 47,090 | D | |
| Common shares without par value | Jun 15, 2017 | S | 100 | $47.981 | D | 46,990 | D | |
| Common shares without par value | Jun 15, 2017 | S | 152 | $47.971 | D | 46,838 | D | |
| Common shares without par value | Jun 15, 2017 | S | 300 | $47.975 | D | 46,538 | D | |
| Common shares without par valueF1 | holding | — | — | — | 469 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of June 15, 2017.
Remarks
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).